RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of HEPA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for Hepion Pharmaceuticals, Inc. as stock downgraded to Hold/Accumulate.
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 21, 2024 Gain 7.33% PDF

The Hepion Pharmaceuticals, Inc. stock price fell by -0.400% on the last day (Thursday, 28th Mar 2024) from $2.50 to $2.49. During the last trading day the stock fluctuated 4.46% from a day low at $2.42 to a day high of $2.53. The price has been going up and down for this period, and there has been a 22.06% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -31 thousand shares and in total, 21 thousand shares were bought and sold for approximately $52.25 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.79% during the next 3 months and, with a 90% probability hold a price between $1.26 and $2.85 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

HEPA Signals & Forecast

The Hepion Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.37 and $2.31. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, March 14, 2024, and so far it has risen 22.06%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Hepion Pharmaceuticals, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.35 and $2.09. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Hepion Pharmaceuticals, Inc. finds support just below today's level at $2.35. If this is broken, then the next support from accumulated volume will be at $2.09 and $1.98.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.108 between high and low, or 4.46%. For the last week the stock has had daily average volatility of 10.15%.

Our recommended stop-loss: $2.39 (-3.90%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 10 days ago.)

Trading Expectations (HEPA) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Hepion Pharmaceuticals, Inc. to open at $2.48, and during the day (based on 14 day Average True Range), to move between $2.20 and $2.78, which gives a possible trading interval of +/-$0.287 (+/-11.51%) up or down from last closing price. If Hepion Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 23.02% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.56 (2.81%) than the support at $2.35 (5.62%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Hepion Pharmaceuticals, Inc. stock A Buy?

Hepion Pharmaceuticals, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.197 Hold/Accumulate Downgraded

Predicted Opening Price for Hepion Pharmaceuticals, Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$2.48 ( 0.428%) $2.49

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for HEPA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.59 3.91 %
R2 2.55 2.25 %
R1 2.52 1.23 %
Current price: 2.49
Support S1 2.44 -2.09 %
S2 2.41 -3.11 %
S3 2.37 -4.77 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.76 10.84 %
R2 2.70 8.43 %
R1 2.56 2.81 %
Current price 2.49
Support S1 2.35 -5.62%
S2 2.09 -16.06%
S3 1.98 -20.48%

FAQ

What is the symbol for Hepion Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Hepion Pharmaceuticals, Inc. is HEPA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Hepion Pharmaceuticals, Inc. Stock?
Hepion Pharmaceuticals, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Hepion Pharmaceuticals, Inc. Stock?
Hepion Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Hepion Pharmaceuticals, Inc. Stock.

What's the current price of Hepion Pharmaceuticals, Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Hepion Pharmaceuticals, Inc. (HEPA) share was $2.49.

What is the 52-week high and low for Hepion Pharmaceuticals, Inc. Stock?
The 52-week high for Hepion Pharmaceuticals, Inc. Stock is $20.66 and the 52-week low is $0.470.

What is the market capitalization of Hepion Pharmaceuticals, Inc. Stock?
As of the 2024-03-28, the market capitalization of Hepion Pharmaceuticals, Inc. is 10.801M.

When is the next earnings date for Hepion Pharmaceuticals, Inc.?
The upcoming earnings date for Hepion Pharmaceuticals, Inc. is Apr 01, 2024.
Click to get the best stock tips daily for free!

About Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals. Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH... HEPA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT